Abstract:CD4 + T cells play a central role in control of L . donovani infection, through IFN-γ production required for activation of macrophages and killing of intracellular parasites. Impaired control of parasites can in part be explained by hampered CD4 + T cells effector functions in visceral leishmaniasis (VL) patients. In a recent studies that defined transcriptional signatures for CD4 + T cells from active VL patients, we found that expression of the IL-7 receptor alpha chain (IL-7R α ; CD127) was downregulated, compared to CD4 + T cells from endemic controls (ECs). Since IL-7 signaling is critical for the survival and homeostatic maintenance of CD4 + T cells, we investigated this signaling pathway in VL patients, relative to ECs. CD4 + T cells were enriched from peripheral blood collected from VL patients and EC subjects and expression of IL7 and IL7RA mRNA was measured by real time qPCR. IL-7 signaling potential and surface expression of CD127 and CD132 on CD4 + T cell was analyzed by multicolor flow cytometry. Plasma levels of soluble IL-7 and sIL-7Rα were measured by ELISA. Transcriptional profiling data sets generated previously from our group showed lower IL7RA mRNA expression in VL CD4 + T cells as compared to EC. A significant reduction was, however not seen when assessing IL7RA mRNA by RT-qPCR. Yet, the levels of soluble IL-7Rα (sIL-7Rα) were reduced in plasma of VL patients compared to ECs. Furthermore, the levels of soluble IL-7 were higher in plasma from VL patients compared to ECs. Interestingly, expression of the IL-7Rα protein was higher on VL patient CD4 + T cells as compared to EC, with activated CD38 + CD4 + T cells showing higher surface expression of IL-7Rα compared to CD38 - CD4 + T cells in VL patients. CD4 + T cells from VL patients had higher signaling potential baseline and after stimulation with recombinant human IL-7 (rhIL-7) compared to EC, as measured by phosphorylation of STAT5 (pSTAT5). Interestingly, it was the CD38 negative cells that had the highest level of pSTAT5 in VL patient CD4 + T cells after IL-7 stimulation. Thus, despite unaltered or potentially lowered IL7RA mRNA expression by CD4 + T cells from VL patients, the surface expression of the IL-7Rα was higher compared to EC and increased pSTAT5 was seen following exposure to rhIL-7. Accordingly, IL-7 signaling appears to be functional and even enhanced in VL CD4 + T cells and cannot explain the impaired effector function of VL CD4 + T cells. The enhanced plasma IL-7 may serve as part of homeostatic feedback mechanism regulating IL7RA expression in CD4 + T cells. In visceral leishmaniasis (VL), antigen specific CD4 + T cell responses are muted hindering the control of the Leishmania donovani infection. IL-7 signaling is crucial for CD4 + T cell survival and function, and gene expression analysis indicated that the IL-7 pathway could be altered in VL. Thus, we investigate if impaired IL-7 signaling could explain the loss of antigen specific T cell response in VL. Although we didn't observe significant reduction of IL7RA mRNA by RT-qPCR, yet, the levels of soluble IL-7Rα (sIL-7Rα) were reduced in plasma of VL patients compared to ECs. Furthermore, the levels of soluble IL-7 were higher in plasma from VL patients compared to ECs and their CD4 + T cells exhibited heightened IL-7 receptor protein expression. Surprisingly, VL patient CD4 + T cells showed increased IL-7 signaling potential, as evidenced by higher phosphorylation of STAT5 upon IL-7 stimulation. While altered, the findings presented here do not attributed the impaired effector function of VL CD4 + T cells to defective IL-7 signaling. We speculate that the elevated plasma IL-7 is part of a homeostatic feedback mechanism in response to the reduced IL7RA transcription in CD4 + T cells.

IL-7Rα on CD4+ T cells is required for their survival and the pathogenesis of experimental autoimmune encephalomyelitis

IL-7 Receptor Polymorphisms is Related to Signaling Strength Which is Associated with Autoimmune T Cells Activation in Multiple Sclerosis

IL-7: Comprehensive review

Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells

Cell Biology of IL-7, a Key Lymphotrophin.

Engagement of B7 on Effector T Cells by Regulatory T Cells Prevents Autoimmune Disease.

Expression and function of the interleukin 7 receptor in murine lymphocytes

Absence of both IL-7 and IL-15 severely impairs the development of CD8 T cell response against Toxoplasma gondii

Collaboration between IL-7 and IL-15 enables adaptation of tissue-resident and circulating memory CD8 T cells

Altered IL-7 signaling in CD4 + T cells from patients with visceral leishmaniasis

Prosurvival IL-7–Stimulated Weak Strength of mTORC1-S6K Controls T Cell Memory via Transcriptional FOXO1–TCF1–Id3 and Metabolic AMPKα1–ULK1–ATG7 Pathways

IL-7 is essential for accumulation of antigen-specific CD8 T cells and to generate clonotype-specific effector responses during airway influenza/A infection

IL-7 Receptor Signals Inhibit Expression of Transcription Factors TCF-1, LEF-1, and RORγt

Interleukin-6 Derived from the Central Nervous System May Influence the Pathogenesis of Experimental Autoimmune Encephalomyelitis in a Cell-Dependent Manner

IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells

The interleukin 7 receptor is required for T cell receptor gamma locus accessibility to the V(D)J recombinase

Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma

Generation of a Novel T Cell Specific Interleukin-1 Receptor Type 1 Conditional Knock Out Mouse Reveals Intrinsic Defects in Survival, Expansion and Cytokine Production of CD4 T Cells

IL-7-dependent and -independent lineages of IL-7R-dependent human T cells

Enhanced CD8 T-cell anti-viral function and clinical disease in B7-H1-deficient mice requires CD4 T cells during encephalomyelitis

Interleukin-7 Biology and Its Effects on Immune Cells: Mediator of Generation, Differentiation, Survival, and Homeostasis